The clinical and urodynamic results of a 3-month percutaneous posterior
tibial nerve stimulation treatment in patients with multiple sclerosis related
neurogenic bladder dysfunction
View
or print this bulletin in its original format.
Medical Update Memo
May 4, 2009
SUMMARY
Bladder symptoms in MS are common. Among them there is the bladder over activity, which can be very distressing. The aim of the study was to investigate the effectiveness of percutaneous posterior tibial nerve stimulation (PTNS) treatment in people with MS and bladder overactivity. Based on results, the investigators suggest that this treatment may be promising in clinical practice in the future. Neurourol Urodyn. 2009 Apr 16
DETAILS
The aim of this study was to investigate the effect of PTNS on the urodynamic findings in the Multiple Sclerosis (MS) patients with overactive bladder, resulting from neurogenic detrusor overactivity (NDO).
PTNS involves sending a mild electrical current through the tibial nerve in the leg, via a small electrode inserted just under the skin at the back of the leg.
A total of 19 MS patients with NDO were enrolled in the study. PTNS was carried out on study participants weekly for 12 weeks. Urodynamic studies before starting, and after 12 weeks of PTNS treatment were performed. The effects of PTNS on urodynamic variables were compared between baseline and after 12 weeks of treatment . While the study sample size was small, these results suggest the possibility that PTNS may be effective in suppressing NDO in MS patients.
National Research and Programs
Offert en français.
Disclaimer
The Multiple Sclerosis Society of Canada is an independent, voluntary health
agency and does not approve, endorse or recommend any specific product or therapy,
but provides information to assist individuals in making their own decisions.
Back
to top  |
